BBN Bellevue Group AG
Bellevue Group AG engages in the asset management business in Switzerland, the United Kingdom, Germany, and internationally. The company offers healthcare investment solutions, including biotech, medtech, thematic, and healthcare global and regional. It also provides small and mid-sized entrepreneur investment solutions, such as listed small and mid-caps, and private equity strategies; and multi asset and bond solutions. The company was founded in 1993 and is headquartered in Zurich, Switzerland.…
Industry Peers
Asset ManagementKey Statistics
About Bellevue Group (SWX: BBN)
›
Bellevue Group (SWX: BBN) is listed on the SIX Swiss Exchange, where its shares trade in CHF. It belongs to the Asset Management industry, part of the Financial Services sector, and reports about 69 employees.
The shares were at 6.580 CHF on 19 November 2026, down 25.4% over 52 weeks. Its 52-week range is 6.560 CHF to 12.40 CHF, and it trades at the bottom of that range.
At a market capitalisation of 88.04M CHF, it trades at 25.3 times trailing earnings and 6.0 times forward earnings. The median trailing P/E of its 18 largest Asset Management peers is 15.2, a premium of 67% for BBN. It pays a dividend yielding 2.27% (it pays out 58% of its earnings), against a median of 1.80% among the dividend payers in that peer group.
Bellevue Group reports return on equity of 1.6%, an operating margin of 11.4% and revenue up 3.9% year over year.
It holds more cash than debt, a net cash position of 18.02M CHF. Its Piotroski F-score is 6 out of 9, an average reading of its financial health.